Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging.
Johnson
Peter A
PA
Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA.
Hurley
Robin A
RA
Benkelfat
Chawki
C
Herpertz
Sabine C
SC
Taber
Katherine H
KH
D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D001883:Borderline Personality Disorder / Q000000981:diagnostic imaging / Q000503:physiopathology*; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology*; D001931:Brain Mapping; D002794:Choline / Q000378:metabolism; D003193:Compulsive Personality Disorder / Q000503:physiopathology; D003404:Creatinine / Q000378:metabolism; D003863:Depression / Q000150:complications / Q000503:physiopathology; D004569:Electroencephalography / Q000379:methods; D004644:Emotions / Q000502:physiology*; D005260:Female; D005277:Fenfluramine / Q000494:pharmacology; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009415:Nerve Net / Q000503:physiopathology; D018490:Serotonin Agents / Q000494:pharmacology; D014055:Tomography, Emission-Computed / Q000379:methods; D014364:Tryptophan / Q000378:metabolism
D018490:Serotonin Agents; D005277:Fenfluramine; D001224:Aspartic Acid; D014364:Tryptophan; C000179:N-acetylaspartate; D003404:Creatinine; D002794:Choline